advertisement
Yang Y 67
Showing records 1 to 25 | Display all abstracts from Yang Y104469 Corneal Stiffness and Modulus of Normal-Tension Glaucoma in Chinese
Xu Y
American Journal of Ophthalmology 2022; 242: 131-138
104726 A Multicenter Clinical Study of the Automated Fundus Screening Algorithm
Li F
Translational vision science & technology 2022; 11: 22
104312 Micropulse laser trabeculoplasty on Chinese patients with glaucoma or ocular hypertension: average 35 months follow-up results
Yang Y
BMC Ophthalmology 2022; 22: 249
105142 Olaparib, a PARP-1 inhibitor, protects retinal cells from ocular hypertension-associated oxidative damage
Yang Y
Frontiers in cell and developmental biology 2022; 10: 925835
104999 Evaluation of segmental scleral buckling surgery for stage 4A retinopathy of prematurity in China
Zhong Y
Frontiers in medicine 2022; 9: 969861
104977 A New Contact Lens Sensor System for Continuous Intraocular Pressure Monitoring: Evaluation of Safety and Tolerability
Zhang Y
Eye Contact Lens 2022; 48: 439-444
104999 Evaluation of segmental scleral buckling surgery for stage 4A retinopathy of prematurity in China
Yang Y
Frontiers in medicine 2022; 9: 969861
105142 Olaparib, a PARP-1 inhibitor, protects retinal cells from ocular hypertension-associated oxidative damage
Wu J
Frontiers in cell and developmental biology 2022; 10: 925835
104977 A New Contact Lens Sensor System for Continuous Intraocular Pressure Monitoring: Evaluation of Safety and Tolerability
Wei Y
Eye Contact Lens 2022; 48: 439-444
104469 Corneal Stiffness and Modulus of Normal-Tension Glaucoma in Chinese
Ye Y
American Journal of Ophthalmology 2022; 242: 131-138
104651 Glaucoma in rural China (the Rural Epidemiology for Glaucoma in China (REG-China)): a national cross-sectional study
Yao B
British Journal of Ophthalmology 2023; 107: 1458-1466
104312 Micropulse laser trabeculoplasty on Chinese patients with glaucoma or ocular hypertension: average 35 months follow-up results
Huang X
BMC Ophthalmology 2022; 22: 249
104726 A Multicenter Clinical Study of the Automated Fundus Screening Algorithm
Pan J
Translational vision science & technology 2022; 11: 22
105142 Olaparib, a PARP-1 inhibitor, protects retinal cells from ocular hypertension-associated oxidative damage
Lu W
Frontiers in cell and developmental biology 2022; 10: 925835
104469 Corneal Stiffness and Modulus of Normal-Tension Glaucoma in Chinese
Chen Z
American Journal of Ophthalmology 2022; 242: 131-138
104726 A Multicenter Clinical Study of the Automated Fundus Screening Algorithm
Yang D
Translational vision science & technology 2022; 11: 22
104999 Evaluation of segmental scleral buckling surgery for stage 4A retinopathy of prematurity in China
Yin H
Frontiers in medicine 2022; 9: 969861
104312 Micropulse laser trabeculoplasty on Chinese patients with glaucoma or ocular hypertension: average 35 months follow-up results
Liao S
BMC Ophthalmology 2022; 22: 249
104977 A New Contact Lens Sensor System for Continuous Intraocular Pressure Monitoring: Evaluation of Safety and Tolerability
Karunaratne IK; Lee CHC
Eye Contact Lens 2022; 48: 439-444
104999 Evaluation of segmental scleral buckling surgery for stage 4A retinopathy of prematurity in China
Zhao M
Frontiers in medicine 2022; 9: 969861
104312 Micropulse laser trabeculoplasty on Chinese patients with glaucoma or ocular hypertension: average 35 months follow-up results
Zhang F
BMC Ophthalmology 2022; 22: 249
104469 Corneal Stiffness and Modulus of Normal-Tension Glaucoma in Chinese
Xu J
American Journal of Ophthalmology 2022; 242: 131-138
105142 Olaparib, a PARP-1 inhibitor, protects retinal cells from ocular hypertension-associated oxidative damage
Dai Y
Frontiers in cell and developmental biology 2022; 10: 925835
104726 A Multicenter Clinical Study of the Automated Fundus Screening Algorithm
Wu J
Translational vision science & technology 2022; 11: 22
104651 Glaucoma in rural China (the Rural Epidemiology for Glaucoma in China (REG-China)): a national cross-sectional study
Yang X
British Journal of Ophthalmology 2023; 107: 1458-1466
